Pharmalot

By  Ed Silverman

Taking stock of the drug industry, from the lab to the medicine chest. Sign up for the newsletter here.

Drug Industry Overstates Patents
Pharmalot

European Parliament backs WHO effort to create a Covid-19 technology access pool

By Ed Silverman

Hepatitis Drugs
Pharmalot

Pharma trade group scolds Gilead again for misleading information about a rival HIV drug

By Ed Silverman

Pharmalot

Pharmalittle: FDA fast-tracks two BioNTech and Pfizer vaccines; U.S. hospitals running short of remdesivir

By Ed Silverman

Chemotherapy infusion
Pharmalot

How can cancer drug prices better match their benefits? Germany offers a cost-saving model

By Ed Silverman

Hires -- up and down the ladder
Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: BioNTech expects to seek approval for vaccine by year-end; why the FDA chose a 50% threshold for Covid-19 vaccines

By Ed Silverman

Pharmalot

Despite the pandemic, prices for many drugs keep rising

By Ed Silverman

White pills on blue
Pharmalot

Two dozen big drug makers launch a $1 billion fund to develop new antibiotics

By Ed Silverman

Pharmalot

Pharmalittle: Gilead to boost remdesivir supplies in Europe; drug makers announcing $1 billion antibiotic innovation fund

By Ed Silverman

Bruce Clark
Pharmalot

The first round of Covid-19 vaccines is ‘highly unlikely to be a magic bullet,’ Medicago CEO says

By Ed Silverman

Botox Chronic Pain
Pharmalot

AbbVie may face fewer wrinkles after judge suggests a 10-year ban on a Botox rival

By Ed Silverman

Pharmalot

Pharmalittle: Will a coronavirus vaccine be budget-breaking? Europe has deals with Merck and Roche for Covid-19 drugs

By Ed Silverman

Prescription Drug label
Pharmalot

Did a pharma trade group try to sabotage a Dutch government report on compulsory licensing?

By Ed Silverman

Pharmalot

Pharmalittle: U.S. scientists and Moderna squabble over Covid-19 vaccine; BARDA doles out big coronavirus contracts

By Ed Silverman

BTF
Pharmalot

Lobbyists tied to Trump represent more than a dozen companies working on Covid-19

By Ed Silverman

Pharmalot

Johnson & Johnson lowers the price of its TB drug in many poor countries, but is it enough?

By Ed Silverman

Pharmalot

Pharmalittle: Covid-19 trials are marked by disorganization; FDA approves a new type of HIV treatment

By Ed Silverman

Alexion Pharmaceuticals Inc
Pharmalot

Alexion to pay $21 million for failing to record bribes paid to doctors in other countries

By Ed Silverman

Pharmalot

Pharmalittle: Trump officials maintain Covid-19 vaccine won’t be influenced by politics; Novartis pays $678 million to settle kickback charges

By Ed Silverman

Pharmalot

Novartis pays $678 million to settle a long-running case over alleged kickbacks to doctors

By Ed Silverman

Vial and syringe
Pharmalot

Africa Union urges member countries to remove intellectual property barriers to Covid-19 vaccines

By Ed Silverman

Pharmalot

Pharmalittle: FDA sets Covid-19 vaccine guidance; White House grabs much of the remdesivir supply

By Ed Silverman

HHS 2020
Pharmalot

Some U.S. government contracts for Covid-19 research could skirt affordable pricing laws

By Ed Silverman and Nicholas Florko

Opioid Lawyers
Pharmalot

Former Indivior CEO pleads guilty in connection with a scheme to promote Suboxone

By Ed Silverman

Drug pricing
Pharmalot

Canadian court upholds most of a controversial new rule for controlling excessive drug prices

By Ed Silverman

Vertex Pharmaceuticals - sunset
Pharmalot

After years of feuds, Vertex and the U.K. government reach a deal over cystic fibrosis medicines

By Ed Silverman

Pharma

STAT+ Conversations: The state of the pharmaceutical industry, featuring Pharmalot’s Ed Silverman

By Ed Silverman

Pharmalot

Pharmalittle: FDA to issue guidance on Covid-19 vaccines; what remdesivir pricing may really mean

By Ed Silverman

Gilead office remdesivir
Pharmalot

Gilead’s pricing for remdesivir raises questions about the drug’s long-term prospects

By Ed Silverman

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy